Nucleo Longevity

Lithium (low-dose)

lithium orotate · low-dose lithium · microdose lithium

Trace/low-dose lithium promoted for mood, brain aging and longevity.

TipoPrescription drug (at clinical doses)

Prescription drug — use only under medical supervision

Il voto risponde a: What does the human evidence support for: Mood & putative neuroprotection?

Grado

D

Debole

Il voto misura la qualità dell'evidenza, non è un consiglio ad assumere o acquistare.

Classe
Trace element / drug
Uso principale
Mood & putative neuroprotection
Forza evidenza
low
Ultima revisione
2026-07-01

In sintesi

Interesting population signals and a real psychiatric drug at higher doses — but a narrow safety margin and almost no controlled 'microdose' evidence make casual self-supplementation a genuinely bad idea. This is a caution, not a recommendation.

Cosa dice l'evidenza

The longevity interest comes from ecological studies suggesting regions with more lithium in drinking water have lower suicide and, in some analyses, dementia rates, plus lithium's established (high-dose) use in bipolar disorder and preclinical neuroprotection signals. But the leap to 'microdose lithium orotate supplements extend healthspan' is not supported by controlled human trials, supplement products are unregulated in dose and purity, and lithium has a famously narrow therapeutic window — the gap between a therapeutic and a toxic level is small. Grade D reflects weak human evidence for the supplement claim combined with real toxicity potential. We include it mainly to warn, not to endorse.

Studi chiave

  1. [1]

    Lithium in drinking water and suicide/dementia (ecological studies) · observational

    Population associations only — cannot establish a supplement benefit.

    Apri su PubMed
  2. [2]

    Low-dose lithium and cognition/neuroprotection · review

    Hypothesis-generating; controlled human evidence is thin.

    Apri su PubMed
  3. [3]

    Lithium toxicity and monitoring · review

    Narrow safety window; requires medical monitoring.

    Apri su PubMed
Vedi tutti gli studi su PubMed

Meccanismo

Proposed inhibition of GSK-3β and effects on autophagy and neurotrophic signalling underlie the neuroprotection hypothesis; at clinical doses it is a mood stabiliser by incompletely understood mechanisms.

Sicurezza

This is the key point. Lithium has a narrow therapeutic index; even outside clearly toxic ranges it can affect the thyroid and kidneys with chronic use, and it interacts with common drugs (NSAIDs, diuretics, ACE inhibitors) that can raise blood levels dangerously. 'Low-dose' supplements are not quality-controlled. Do not self-experiment: any lithium use belongs under medical supervision with blood monitoring.

Contesto dosaggio

Clinical psychiatric dosing is individualised and monitored with blood tests. 'Microdose' supplement products (e.g. lithium orotate) provide much smaller amounts, but without trials establishing benefit or a safe long-term dose — so no responsible dose can be stated here.

Esempi di applicazione

  • Not self-dosed: any lithium use belongs under medical supervision with blood tests.
  • Population signals are interesting but not a basis for supplements.
  • Included here to caution, not to recommend.

Nota dal campo

This is the entry where our job is to slow you down, not sell you. The population data are genuinely intriguing, but lithium is a real drug with a narrow safety margin and no controlled evidence for the supplement version. Grade D — and please don't microdose lithium on your own.